] Giacconi R, Cipriano C, Albanese F, et al. The −

G/C polymor- phism of IL-

is useful to screen old subjects at risk for atheroscle- rosis or to reach successful ageing. Exp Gerontol

;

:

–

[

] Capurso C, Solfrizzi V, D’Introno A, et al. Interleukin-

−

G/C promoter gene polymorphism in centenarians: no evidence of asso- ciation with human longevity or interaction with apolipoprotein E

from coronary heart disease: a

-year follow-up of

Swedish twins. J Intern Med

;

:

–

[

] Wienke A, Holm NV, Christensen K, et al. The heritability of cause- specific mortality: a correlated gamma-frailty model applied to mor- tality due to respiratory diseases in Danish twins born

–

Stat Med

;

:

–

[

] Mannucci PM, Mari D, Merati G, et al. Gene polymorphisms pre- dicting high plasma levels of coagulation and fibrinolysis proteins. A study in centenarians. Arterioscler Thromb Vasc Biol

;

:

–

[

] Bonafe M, Olivieri F, Cavallone L, et al. A gender-dependent ge- netic predisposition to produce high levels of IL-

is detrimental for longevity. Eur J Immunol

;

:

–

[

] Lio D, Scola L, Crivello A, et al. Allele frequencies of +

T→A single nucleotide polymorphism at the first intron of interferon- gamma gene in a group of Italian centenarians. Exp Gerontol

;

:

–

[

] Fried LP, Borhani NO, Enright P, et al. The cardiovascular health study: design and rationale. Ann Epidemiol

;

:

–

[

] Diehr P, Patrick DL, Bild DE, Burke GL, Williamson JD. Predict- ing future years of healthy life for older adults. J Clin Epidemiol

;

:

–

[

] Diehr P, Newman AB, Jackson SA, Kuller L, Powe N. Weight- modification trials in older adults: what should the outcome measure be? Curr Control Trials Cardiovasc Med

;

:

–

[

] Jenny NS, Tracy RP, Ogg MS, et al. In the elderly, interleukin-

plasma levels and the −

G>C polymorphism are associated with the development of cardiovascular disease. Arterioscler Thromb Vasc Biol

;

:

–

[

] Crainich P, Jenny NS, Tang Z, et al. Lack of association of the plasminogen activator inhibitor-

G/

G promoter polymorphism with cardiovascular disease in the elderly. J Thromb Haemost

;

:

–

[

] Thomas A, Lamlum H, Humphries S, Green F. Linkage disequi- librium across the fibrinogen locus as shown by five genetic poly- morphisms, G/A-

(Ha

II), C/T-

(Hin

II/Al

), T/G+

(Av

I), and Bc

(beta-fibrinogen) and Ta

(alpha-fibrinogen), and their detection by PCR. Hum Mutat

;

:

–

[

] Crainich P, Tang Z, Macy EM, et al. A polymorphism at position −

in the promoter region of thrombin-activatable fibrinolysis in- hibitor (TAFI) is strongly associated with plasma antigen levels in healthy older men and women. Circulation

;

:II-

[

] Suissa S, Edwardes MD, Boivin JF. External comparisons from nested case–control designs. Epidemiology

;

:

–

[

] Lin DY, Wei LJ. The robust inference of the Cox proportional haz- ards model. J Am Stat Assoc

;

:

–

[

] Lamarca R, Alonso J, Gomez G, Munoz A. Left-truncated data with age as time scale: an alternative for survival analysis in the elderly population. J Gerontol A Biol Sci Med Sci

;

:

–

[

] Jackson AU, Galecki AT, Burke DT, Miller RA. Mouse loci as- sociated with life span exhibit sex-specific and epistatic effects. J Gerontol A Biol Sci Med Sci

;

(

):B

–

[January]. [

] Juhan-Vague I, Morange PE, Aubert H, et al. Plasma thrombin- activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe. Arterioscler Thromb Vasc Biol

;

:

–

[

] Bouma BN, Meijers JC. Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, pro- carboxypeptidase U). J Thromb Haemost

;

:

–

[

] Campbell W, Okada N, Okada H. Carboxypeptidase R is an inacti- vator of complement-derived inflammatory peptides and an inhibitor of fibrinolysis. Immunol Rev

;

:

–

[

] Bajzar L, Jain N, Wang P, Walker JB. Thrombin activatable fibri- nolysis inhibitor: not just an inhibitor of fibrinolysis. Crit Care Med

;

:S

–

A.P. Reiner et al. / Atherosclerosis 181 (2005) 175–183

[

] Basso F, Lowe GD, Rumley A, M

ahon AD, Humphries SE. Interleukin-

−

G>C polymorphism and risk of coronary heart disease in West of Scotland coronary prevention study (WOSCOPS). Arterioscler Thromb Vasc Biol

;

:

–

[

] Jones KG, Brull DJ, Brown LC, et al. Interleukin-

(IL-

) and the prognosis of abdominal aortic aneurysms. Circulation

;

:

–

[

] Christiansen L, Bathum L, Andersen-Ranberg K, Jeune B, Chris- tensen K. Modest implication of interleukin-

promoter polymor- phisms in longevity. Mech Ageing Dev

;

:

–

[

] Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymor- phisms in the interleukin-

(IL-

) gene on IL-

transcription and plasma IL-

levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest

;

:

–